esc 2022: the emperor-pooled trial: clinical benefits of sglt2i in heart failure | dr faiez zannad
Published 2 years ago • 324 plays • Length 4:45Download video MP4
Download video MP3
Similar videos
-
7:27
cirse 2022: the effpac trial | prof ulf teichgräber
-
59:59
a new focus on mitral and tricuspid valve disease - europcr 2022
-
7:19
tricuspid valve repair - triluminate clinical trial
-
0:24
triclip setup
-
9:10
triscend ii: transcatheter tricuspid valve replacement in patients with severe tr
-
25:19
hatch d2 - physican examination & pertinent clinical pearls for the diagnosis of pad - dr. kosinski
-
0:26
pascal/pascal ace transcatheter repair system restoring mitral valve function | pcr expert interview
-
8:01
the real reason why we are getting sicker
-
10:13
the big step: part two - an untested procedure promising cerebral palsy cure | 60 minutes australia
-
51:52
the serendipitous story of sglt2i in the treatment of heart failure
-
3:23
esc 2022: the pre18ffir trial: 18f-naf pet for vulnerable coronary plaque imaging after mi
-
1:20:10
[tctap 2023] live case & lecture #17: tricuspid
-
1:00:39
tricuspid valve from diagnosis to new treatments - webinar
-
17:15
dr. peter liu: impact of the latest therapies
-
46:13
bad stroke & the 5 ps 6/8/16
-
2:26
pcr e-course highlights: treating tricuspid regurgitation with the pascal repair system
-
58:54
pcr tricuspid special focus issue | jacc: case reports video discussion
-
51:53
pcr e-course: treating tricuspid regurgitation with the pascal repair system
-
16:46
dr daniel sessler from the cleveland clinic talks with dr candice peters
-
1:02:05
[tctap2022 - hot debates 2022] chest pain evaluation: new chest pain guideline and its implication
-
2:52
acc.16 | surgical treatment of ischemic mitral regurgitation